中草药

“聚于胃，关于肺”视角下探索胃食管反流病与慢性阻塞性肺疾病的因果关系及干预中药预测

PDF下载

中草药 | 数据挖掘与循证医学 2026,57(3): 1014-1031

收起

中草药 |数据挖掘与循证医学 2026 , 57 (3) : 1014 -1031

“聚于胃，关于肺”视角下探索胃食管反流病与慢性阻塞性肺疾病的因果关系及干预中药预测

全屏

张文娟¹, 李江², 孙艳丽¹, 李倩¹, 张昀华³, 成晓萌¹, 钟晓曼¹, 黎白银¹, 邓翔文¹, 吴建军¹

作者信息

通讯作者:

吴建军

作者简介:

张文娟: 张文娟，博士研究生，研究方向为中医药防治呼吸系统疾病。E-mail:2403363019@qq.com

Exploring causal relationship between gastroesophageal reflux disease and chronic obstructive pulmonary disease and predicting interventional traditional Chinese medicines from perspective of “gather in stomach and focus on lung”

ZHANG Wenjuan, LI Jiang, SUN Yanli, LI Qian, ZHANG Yunhua, CHENG Xiaomeng, ZHONG Xiaoman, LI Baiyin, DENG Xiangwen, WU Jianjun

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.03.019

文章导航

摘要

收起

目的基于“聚于胃，关于肺”理论，通过孟德尔随机化（Mendelian randomization，MR）分析探讨胃食管反流病（gastro-esophageal reflux disease，GERD）与慢性阻塞性肺疾病（chronic obstructive pulmonary disease，COPD）的遗传因果关系，并预测可干预GERD相关性COPD的潜在中药。方法从IEU Open GWAS数据库获取GERD与COPD的全基因组关联研究数据集，采用双向MR分析评估二者的因果关系，并进行系列质量控制。随后，通过Ensembl数据库提取工具变量邻近基因，并利用功能富集分析探索GERD影响COPD发生风险的潜在机制。进而，对上述邻近基因进行蛋白质-蛋白质互作（protein-protein interaction，PPI）分析，以筛选参与该过程的核心基因。通过毒性与基因比较数据库（Comparative Toxicogenomics Database，CTD）和Coremine Medical数据库分别对潜在干预化学成分及中药进行预测，并对中药的药性功用信息进行统计分析。采用CytoNCA插件筛选核心中药，并进行中药成分与核心基因的分子对接初步佐证预测结果。结果正向MR分析提示，GERD与COPD发病风险显著增加存在因果关联；质量控制结果证实该结果稳健。反向MR分析未发现COPD对GERD存在因果关联的证据。共获取到135个工具变量邻近基因，主要富集在核因子κB（nuclear factor-κB，NF-κB）信号转导的调控、白细胞介素-17（interleukin-17，IL-17）信号通路、肿瘤坏死因子（tumor necrosis factor，TNF）信号通路、磷脂酰肌醇-3-羟激酶（phosphatidylinositol-3-hydroxykinase，PI3K）/蛋白激酶B（protein kinase B，Akt）信号通路、自然杀伤细胞介导的细胞毒性等生物学途径。将PPI分析筛选到的前5个基因确定为核心基因。利用CTD及Coremine Medical数据库共预测到163个化学成分和167味中药。中药四气以寒、温为主，平次之；五味以苦、甘、辛为主；归经以肺经为主，肝、脾、胃经次之；功效以补虚、化痰止咳平喘为主，清热、解表、理气次之。CytoNCA计算后，筛选出关键中药麻黄、白果、半夏、陈皮、桑白皮、甘草、干姜、生姜、黄芪、人参、茯苓、白术，分子对接显示核心基因与中药关键成分具有较好的结合能力。结论基于“聚于胃，关于肺”理论，不仅从遗传学视角证实了GERD是COPD的致病风险因素，亦揭示了其潜在机制与NF-κB、IL-17、TNF、PI3K-Akt等炎症与免疫信号通路密切相关，预测的中药治法以补虚、化痰止咳平喘为主。

关键词

胃食管反流病 / 慢性阻塞性肺疾病 / “聚于胃，关于肺” / 孟德尔随机化 / 半夏 / 人参 / 茯苓 / 白术

Abstract

收起

Objective To explore the genetic causal relationship between gastro-esophageal reflux disease (GERD) and chronic obstructive pulmonary disease (COPD) by Mendelian randomization (MR) analysis based on the theory of “gather in stomach and focus on lung”, and to predict potential Chinese herbal medicines that may intervene in GERD-related COPD. Methods The genome-wide association study (GWAS) datasets for GERD and COPD were obtained from the IEU Open GWAS database. A bidirectional two-sample Mendelian randomization (MR) analysis was applied to evaluate the causal relationship between the two conditions, followed by a series of quality control procedures. Subsequently, proximal genes of the instrumental variables were extracted using the Ensembl database, and functional enrichment analysis was performed to explore the potential mechanisms by which GERD influences COPD risk. Furthermore, protein-protein interaction (PPI) analysis was conducted on these proximal genes to identify core genes involved in this process. Potential intervention chemical components and Chinese herbal medicines were predicted using the Comparative Toxicogenomics Database (CTD) and the Coremine Medical database, respectively, and statistical analysis was carried out on the medicinal properties and functions of the identified herbs. The CytoNCA plugin was used to screen core Chinese herbal medicines, and molecular docking of traditional Chinese medicine components with core genes to preliminarily verify the prediction results. Results Forward MR analysis indicated that GERD was causally associated with a significantly increased risk of COPD onset; quality control results confirmed the robustness of this finding. Reverse MR analysis did not reveal evidence supporting a causal effect of COPD on GERD. A total of 135 proximal genes of the instrumental variables were identified, which were primarily enriched in biological pathways such as the regulation of Nuclear Factor-Kappa B (NF-κB) signal transduction, the Interleukin-17 (IL-17) signaling pathway, the Tumor Necrosis Factor (TNF) signaling pathway, the Phosphatidylinositol 3-Kinase-Protein Kinase B (PI3K-Akt) signaling pathway, and natural killer cell-mediated cytotoxicity. The top five genes identified through PPI analysis were determined as core genes. Using the CTD and Coremine Medical databases, 163 chemical components and 167 Chinese herbal medicines were predicted. Statistical analysis of the medicinal properties of the herbs showed that among the Four Natures, cold and warm properties predominated, followed by neutral; among the five flavors, bitter, sweet, and pungent were most common; the primary meridian tropism was the lung meridian, followed by the liver, spleen, and stomach meridians; in terms of functions, tonifying deficiency and resolving phlegm, relieving cough and asthma were primary, followed by clearing heat, relieving exterior syndrome, and regulating qi. After calculation with CytoNCA, key herbs were screened out, including Mahuang (Ephedrae Herba), Baiguo (Ginkgo Semen), Banxia (Pinelliae Rhizoma), Chenpi (Citri Reticulatae Pericarpium), Sangbaipi (Mori Cortex), Gancao (Glycyrrhizae Radix et Rhizoma), Ganjiang (Zingiberis Rhizoma), Shengjiang (Zingiberis Rhizoma Recens), Huangqi (Astragali Radix), Renshen (Ginseng Radix et Rhizoma), Fuling (Poria), and Baizhu (Atractylodis Macrocephalae Rhizoma). Molecular docking demonstrated favorable binding affinity between the core genes and the key components of these Chinese herbal medicines. Conclusion Based on the theory of "accumulation in the stomach and its connection with the lungs," this study not only confirms from a genetic perspective that GERD is a risk factor for COPD, but also reveals that its potential mechanisms are closely associated with inflammatory and immune signaling pathways such as NF-κB, IL-17, TNF, and PI3K-Akt. The predicted Chinese herbal treatment strategies primarily focus on tonifying deficiency, resolving phlegm, relieving cough, and calming asthma.

Key words

gastroesophageal reflux disease / chronic obstructive pulmonary disease / gather in stomach and focus on lung / Mendelian randomization / Pinelliae Rhizoma / Ginseng Radix et Rhizoma / Poria / Atractylodis Macrocephalae Rhizoma

引用本文

张文娟, 李江, 孙艳丽, 李倩, 张昀华, 成晓萌, 钟晓曼, 黎白银, 邓翔文, 吴建军. “聚于胃，关于肺”视角下探索胃食管反流病与慢性阻塞性肺疾病的因果关系及干预中药预测. 中草药, 2026 , 57 (3) : 1014 -1031 . DOI: 10.7501/j.issn.0253-2670.2026.03.019

ZHANG Wenjuan, LI Jiang, SUN Yanli, LI Qian, ZHANG Yunhua, CHENG Xiaomeng, ZHONG Xiaoman, LI Baiyin, DENG Xiangwen, WU Jianjun. Exploring causal relationship between gastroesophageal reflux disease and chronic obstructive pulmonary disease and predicting interventional traditional Chinese medicines from perspective of “gather in stomach and focus on lung”[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (3) : 1014 -1031 . DOI: 10.7501/j.issn.0253-2670.2026.03.019

基金

收起

国家自然科学基金项目(82274462);国家自然科学基金项目(82575036);北京市自然科学基金项目(7232284);国家中医药管理局第五批全国中医临床优秀人才研修项目(国中医药人教函[2022]1号);北京市中医药管理局北京中医药新时代125工程(京中医药科字[2025]2号);北京中医药大学第三附属医院精诚人才计划(京中三院人[2025]4号)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

Agustí A, Celli B R, Criner G J, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary [J]. Eur Respir J, 2023, 61(4): 2300239.
Lea S, Higham A, Beech A, et al. How inhaled corticosteroids target inflammation in COPD [J]. Eur Respir Rev, 2023, 32(170): 230084.
de Oca M M, Perez-Padilla R, Celli B, et al. The global burden of COPD: Epidemiology and effect of prevention strategies [J]. Lancet Respir Med, 2025, 13(8): 709-724.
Maret-Ouda J, Markar S R, Lagergren J. Gastroesophageal reflux disease [J]. Jama, 2020, 324(24): 2565.
Scarpignato C, Hongo M, Wu J C Y, et al. Pharmacologic treatment of GERD: Where we are now, and where are we going? [J]. Ann N Y Acad Sci, 2020, 1482(1): 193-212.
Fox M, Forgacs I. Gastro-oesophageal reflux disease [J]. Bmj, 2006, 332(7533): 88-93.
Li N, Yang W L, Cai M H, et al. Burden of gastroesophageal reflux disease in 204 countries and territories, 1990—2019: A systematic analysis for the Global Burden of disease study 2019 [J]. BMC Public Health, 2023, 23(1): 582.
Zhang D C, Liu S J, Li Z Q, et al. Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: Update from the GBD 2019 study [J]. Ann Med, 2022, 54(1): 1372-1384.
Tanimura K, Muro S. Gastroesophageal reflux disease in chronic obstructive pulmonary disease [J]. Respir Investig, 2024, 62(5): 746-758.
Huang C R, Liu Y H, Shi G C. A systematic review with meta-analysis of gastroesophageal reflux disease and exacerbations of chronic obstructive pulmonary disease [J]. BMC Pulm Med, 2020, 20(1): 2.
Kim J, Lee J H, Kim Y, et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: A national cross-sectional cohort study [J]. BMC Pulm Med, 2013, 13: 51.
Kang H H, Seo M, Lee J, et al. Reflux esophagitis in patients with chronic obstructive pulmonary disease [J]. Medicine, 2021, 100(34): e27091.
Lee A L, Goldstein R S. Gastroesophageal reflux disease in COPD: Links and risks [J]. Int J Chron Obstruct Pulmon Dis, 2015, 10: 1935-1949.
Yu F, Huang Q H, Ye Y S, et al. Effectiveness of proton-pump inhibitors in chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials [J]. Front Med, 2022, 9: 841155.
Larsson S C, Butterworth A S, Burgess S. Mendelian randomization for cardiovascular diseases: Principles and applications [J]. Eur Heart J, 2023, 44(47): 4913-4924.
Birney E. Mendelian randomization [J]. Cold Spring Harb Perspect Med, 2021: a041302.
Sekula P, Del Greco M F, Pattaro C, et al. Mendelian randomization as an approach to assess causality using observational data [J]. J Am Soc Nephrol, 2016, 27(11): 3253-3265.
Apalowo O E, Walt H K, Alaba T E, et al. Exploring the potential roles of SLC39A8 and POC5 missense variants in the association between body composition, beverage consumption, and chronic lung diseases: A two-sample Mendelian randomization study [J]. Int J Mol Sci, 2025, 26(16): 7799.
Wang B M, Bai X Y, Yang Y M, et al. Possible linking and treatment between Parkinson’s disease and inflammatory bowel disease: A study of Mendelian randomization based on gut-brain axis [J]. J Transl Med, 2025, 23(1): 45.
Yang W W, Yang Y J, He L, et al. Dietary factors and risk for asthma: A Mendelian randomization analysis [J]. Front Immunol, 2023, 14: 1126457.
Kamat M A, Blackshaw J A, Young R, et al. PhenoScanner V2: An expanded tool for searching human genotype-phenotype associations [J]. Bioinformatics, 2019, 35(22): 4851-4853.
吴宣諭, 肖祥, 陈嘉靖, 等. 基于“肠-肺轴”探讨肠道菌群与特发性肺纤维化的遗传因果关联及干预中药预测 [J]. 中草药, 2024, 55(17): 5921-5937.
Bi Y R, Liu Y J, Wang H Y, et al. The association of alanine aminotransferase and diabetic microvascular complications: A Mendelian randomization study [J]. Front Endocrinol, 2023, 14: 1104963.
Guan X Q, Zhang D, Zhang F Y, et al. Causal association of physical activity with low back pain, intervertebral disc degeneration and sciatica: A two-sample Mendelian randomization analysis study [J]. Front Cell Dev Biol, 2023, 11: 1260001.
Yoshikawa M, Asaba K. Educational attainment decreases the risk of COVID-19 severity in the European population: A two-sample Mendelian randomization study [J]. Front Public Health, 2021, 9: 673451.
Xu S H, Liu Y F, Wang Q, et al. Mendelian randomization study reveals a causal relationship between coronary artery disease and cognitive impairment [J]. Front Cardiovasc Med, 2023, 10: 1150432.
Wang Q S, Shi Q Q, Lu J W, et al. Causal relationships between inflammatory factors and multiple myeloma: A bidirectional Mendelian randomization study [J]. Int J Cancer, 2022, 151(10): 1750-1759.
Duan L C, Chen D Q, Shi Y, et al. Rheumatoid arthritis and hypothyroidism: A bidirectional Mendelian randomization study [J]. Front Immunol, 2023, 14: 1146261.
Liao W Z, Zhou Z Y, Lin Z K, et al. Coffee consumption and periodontitis: A Mendelian randomization study [J]. Genes Nutr, 2023, 18(1): 13.
Nie X L, Liu Z L, Xie D H, et al. Inflammatory arthritis and eye diseases: A Mendelian randomization study [J]. Front Endocrinol, 2023, 14: 1251167.
Jiang M M, Yan W H, Li X J, et al. Calcium homeostasis and psychiatric disorders: A Mendelian randomization study [J]. Nutrients, 2023, 15(18): 4051.
黄洁雅, 郜文辉, 杨仁义, 等. “诸气膹郁，皆属于肺”视域下探讨肺腺癌相关性抑郁因果关系及干预中药预测 [J]. 中草药, 2025, 56(8): 2885-2897.
Jian C X, Xia J, Wang N S, et al. Mendelian randomization analysis with the GEO database: Exploring the molecular mechanism underlying insulin therapy for perioperative neurocognitive disorders [J]. Eur J Pharmacol, 2025, 1002: 177843.
Wu Z L, Zhao Z L, Li Y, et al. Identification of key genes and immune infiltration in peripheral blood biomarker analysis of delayed cerebral ischemia: Valproic acid as a potential therapeutic drug [J]. Int Immunopharmacol, 2024, 137: 112408.
田楠楠, 杨茜和, 朱雅暄, 等. 麻黄的化学成分及其药效作用和药代特征 [J]. 中国中药杂志, 2022, 47(13): 3409-3424.
夏梦雨, 张雪, 王云, 等. 白果的炮制方法、化学成分、药理活性及临床应用的研究进展 [J]. 中国药房, 2020, 31(1): 123-128.
王嘉蕊, 张甜, 蓝鑫, 等. 茯苓化学成分、药理活性、药食同源应用研究进展 [J/OL]. 中成药 (2025-04-18) [2026-01-15]. https://link.cnki.net/urlid/31.1368.R.20250417. 1731.004.
张柂儇, 刘海龙, 王瑞琼, 等. 黄芪化学成分和药理作用及Q-marker预测分析 [J]. 中国新药杂志, 2023, 32(4): 410-419.
顾思浩, 孔维崧, 张彤, 等. 白术的化学成分与药理作用及复方临床应用进展 [J]. 中华中医药学刊, 2020, 38(1): 69-73.
刘伟, 刘永博, 王梓, 等. 人参的化学成分与转化机理研究进展 [J]. 吉林农业大学学报, 2023, 45(6): 664-673.
刘龙婵, 王星宇, 李林楠, 等. 青皮与陈皮化学成分及分析方法研究进展 [J]. 中国中药杂志, 2022, 47(11): 2866-2879.
张嘉欣, 朱珠, 孙念霞, 等. 桑白皮化学成分、药理作用研究进展及其质量标志物预测 [J]. 中草药, 2025, 56(9): 3340-3353.
刘怡妙, 凌悦, 徐旭, 等. 生姜的研究进展及其质量标志物的预测分析 [J]. 中草药, 2022, 53(9): 2912-2928.
周亚丽, 杨萍, 李喜香, 等. 半夏化学成分与药理作用研究进展及其质量标志物 (Q-Marker) 预测 [J]. 中草药, 2024, 55(14): 4939-4952.
王苗苗. 甘草的化学成分及生物活性研究 [D]. 济南: 山东大学, 2020.
Liu Y, Yang X C, Gan J H, et al. CB-Dock2: Improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting [J]. Nucleic Acids Res, 2022, 50(W1): W159-W164.
Antypenko L, Shabelnyk K, Antypenko O, et al. In silico identification and characterization of spiro [1, 2, 4] triazolo [1, 5-c] quinazolines as diacylglycerol kinase α modulators [J]. Molecules, 2025, 30(11): 2324.
卫亚丽. 基于“聚于胃，关于肺”理论探讨从肺胃论治慢性荨麻疹 [D]. 北京: 中国中医科学院, 2022.
姚菲, 唐春回, 梁飞红. 基于 “聚于胃关于肺” 理论从调 “谷道”通“气道”治疗肺系疾病 [J]. 中国中医药信息杂志, 2019, 26(6): 116-118.
Iov D E, Bărboi O B, Floria M, et al. Pepsin and the lung: Exploring the relationship between micro-aspiration and respiratory manifestations of gastroesophageal reflux disease [J]. J Pers Med, 2022, 12(8): 1296.
Broers C, Tack J, Pauwels A. Review article: Gastro-oesophageal reflux disease in asthma and chronic obstructive pulmonary disease [J]. Aliment Pharmacol Ther, 2018, 47(2): 176-191.
Durazzo M, Lupi G, Cicerchia F, et al. Extra-esophageal presentation of gastroesophageal reflux disease: 2020 update [J]. J Clin Med, 2020, 9(8): 2559.
Ali Imanifooladi A, Yazdani S, Nourani M R. The role of nuclear factor-kappaB in inflammatory lung disease [J]. Inflamm Allergy Drug Targets, 2010, 9(3): 197-205.
Gilmore T D. Introduction to NF-kappaB: Players, pathways, perspectives [J]. Oncogene, 2006, 25(51): 6680-6684.
Adcock I M, Caramori G, Barnes P J. Chronic obstructive pulmonary disease and lung cancer: New molecular insights [J]. Respiration, 2011, 81(4): 265-284.
Schuliga M. NF-kappaB signaling in chronic inflammatory airway disease [J]. Biomolecules, 2015, 5(3): 1266-1283.
Sadikot R T, Zeng H, Joo M, et al. Targeted immunomodulation of the NF-kappaB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa [J]. J Immunol, 2006, 176(8): 4923-4930.
Jiang H H, Abel P W, Toews M L, et al. Phosphoinositide 3-kinase gamma regulates airway smooth muscle contraction by modulating calcium oscillations [J]. J Pharmacol Exp Ther, 2010, 334(3): 703-709.
Stockley J A, Walton G M, Lord J M, et al. Aberrant neutrophil functions in stable chronic obstructive pulmonary disease: The neutrophil as an immunotherapeutic target [J]. Int Immunopharmacol, 2013, 17(4): 1211-1217.
Lu J, Xie L, Liu C, et al. PTEN/PI₃k/AKT regulates macrophage polarization in emphysematous mice [J]. Scand J Immunol, 2017, 85(6): 395-405.
Wang Z Y, Li R, Zhong R. Extracellular matrix promotes proliferation, migration and adhesion of airway smooth muscle cells in a rat model of chronic obstructive pulmonary disease via upregulation of the PI3K/AKT signaling pathway [J]. Mol Med Rep, 2018, 18(3): 3143-3152.
Yao H W, Rahman I. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease [J]. Toxicol Appl Pharmacol, 2011, 254(2): 72-85.
Marwick J A, Adcock I M, Chung K F. Overcoming reduced glucocorticoid sensitivity in airway disease: Molecular mechanisms and therapeutic approaches [J]. Drugs, 2010, 70(8): 929-948.
Antczak A, Ciebiada M, Pietras T, et al. Exhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary disease [J]. Arch Med Sci, 2012, 8(2): 277-285.
Liu T. miR-937 serves as an inflammatory inhibitor in cigarette smoke extract-induced human bronchial epithelial cells by targeting IL1B and regulating TNF-α/IL-17 signaling pathway [J]. Tob Induc Dis, 2021, 19: 55.
Hodge G, Mukaro V, Holmes M, et al. Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway [J]. Respirology, 2013, 18(2): 369-376.
Cordeiro Q, Cappi C, Santos Sampaio A, et al. Association study between the-62A/T NFKBIL1 polymorphism and obsessive-compulsive disorder [J]. Braz J Psychiatry, 2009, 31(2): 131-135.
Allcock R J, de la Concha E G, Fernandez-Arquero M, et al. Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster [J]. Hum Immunol, 1999, 60(12): 1266-1273.
Okamoto K, Makino S, Yoshikawa Y, et al. Identification of IκBL as the second major histocompatibility complex–linked susceptibility locus for rheumatoid arthritis [J]. Am J Hum Genet, 2003, 72(2): 303-312.
Yamashita T, Hamaguchi K, Kusuda Y, et al. IKBL promoter polymorphism is strongly associated with resistance to type 1 diabetes in Japanese [J]. Tissue Antigens, 2004, 63(3): 223-230.
Shibata H, Yasunami M, Obuchi N, et al. Direct determination of single nucleotide polymorphism haplotype of NFKBIL1 promoter polymorphism by DNA conformation analysis and its application to association study of chronic inflammatory diseases [J]. Hum Immunol, 2006, 67(4/5): 363-373.
Kominami S, Tanabe N, Ota M, et al. HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis [J]. J Hum Genet, 2009, 54(2): 108-114.
Allcock R J N, Williams J H, Price P. The central MHC gene, BAT1 may encode a protein that down-regulates cytokine production [J]. Genes Cells, 2001, 6(5): 487-494.
Szymura S J, Bernal G M, Wu L T, et al. DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-κB and sensitize to alkylating chemotherapy [J]. BMC Biol, 2020, 18(1): 32.
Hirano M, Galarza-Muñoz G, Nagasawa C, et al. The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate [J]. Elife, 2023, doi: 10.7554/eLife.76927.
Jackson D M, Simpson W T. The effect of dopamine on the rapidly adapting receptors in the dog lung [J]. Pulm Pharmacol Ther, 2000, 13(1): 39-42.
Birrell M A, Crispino N, Hele D J, et al. Effect of dopamine receptor agonists on sensory nerve activity: Possible therapeutic targets for the treatment of asthma and COPD [J]. Br J Pharmacol, 2002, 136(4): 620-628.
Bonnert R V, Brown R C, Chapman D, et al. Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues [J]. J Med Chem, 1998, 41(25): 4915-4917.
Bruzzone P, D’Andrea V, Motta C, et al. Occurrence of dopaminergic (D(2)) receptors within the rabbit pulmonary circulation [J]. Pulm Pharmacol Ther, 2002, 15(4): 393-398.
Xie G X, Jones K, Peroutka S J, et al. Detection of mRNAs and alternatively spliced transcripts of dopamine receptors in rat peripheral sensory and sympathetic ganglia [J]. Brain Res, 1998, 785(1): 129-135.
Konings G F J, Reynaert N L, Delvoux B, et al. Increased levels of enzymes involved in local estradiol synthesis in chronic obstructive pulmonary disease [J]. Mol Cell Endocrinol, 2017, 443: 23-31.
van Loo G, Bertrand M J M. Death by TNF: A road to inflammation [J]. Nat Rev Immunol, 2023, 23(5): 289-303.
Barnes P J. The cytokine network in chronic obstructive pulmonary disease [J]. Am J Respir Cell Mol Biol, 2009, 41(6): 631-638.
Aaron S D, Angel J B, Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Med, 2001, 163(2): 349-355.
Lundblad L K A, Thompson-Figueroa J, Leclair T, et al. Tumor necrosis factor-alpha overexpression in lung disease: A single cause behind a complex phenotype [J]. Am J Respir Crit Care Med, 2005, 171(12): 1363-1370.
Nagaya H, Satoh H, Maki Y. Actions of antisecretory agents on proton transport in hog gastric microsomes [J]. Biochem Pharmacol, 1987, 36(4): 513-519.
Singh R, Singh B, Singh S, et al. Anti-free radical activities of kaempferol isolated from Acacia nilotica (L.) Willd. Ex. Del [J]. Toxicol In Vitro, 2008, 22(8): 1965-1970.
丁敏, 甄海宁, 王倩, 等. 山柰酚通过抑制PI3K/AKT信号通路抑制COPD模型细胞炎症反应和细胞外基质损伤 [J]. 中药材, 2024, 47(8): 2063-2066.
Rao C V, Vijayakumar M. Effect of quercetin, flavonoids and alpha-tocopherol, an antioxidant vitamin, on experimental reflux oesophagitis in rats [J]. Eur J Pharmacol, 2008, 589(1/2/3): 233-238.
魏萍, 陈志斌, 王春娥, 等. 槲皮素对慢性阻塞性肺疾病大鼠的保护作用 [J]. 中国免疫学杂志, 2019, 35(21): 2570-2575.
Ding L, Qi H Y, Wang Y S, et al. Recent advances in ginsenosides against respiratory diseases: Therapeutic targets and potential mechanisms [J]. Biomed Pharmacother, 2023, 158: 114096.
刘力维, 赵霞. 基于黄芪多糖的药理学研究探讨其在哮喘缓解期的作用 [J]. 辽宁中医杂志, 2016, 43(8): 1780-1783.
陈家亮, 李琪, 周向东, 等. 川陈皮素对慢性阻塞性肺疾病模型大鼠气道黏液高分泌的抑制作用及其分子机制 [J]. 吉林大学学报: 医学版, 2024, 50(2): 295-302.
廖一羲, 邱志广, 王搏, 等. 基于网络药理学及分子对接探究川陈皮素止咳、祛痰、平喘作用机制 [J]. 中国老年学杂志, 2025, 45(9): 2136-2144.
徐健, 曾万祥, 王晓东, 等. 陈皮的化学成分与药理学作用研究进展 [J]. 中国野生植物资源, 2022, 41(10): 72-76.
杨昱斌, 范欣生, 周丽萍, 等. 桑白皮及其相关方剂治疗呼吸系统疾病的研究进展 [J]. 中国实验方剂学杂志, 2022, 28(19): 241-249.
路平, 史汶龙, 杨思雨, 等. 茯苓化学成分及药理作用研究进展 [J]. 中成药, 2024, 46(4): 1246-1254.

2026年第57卷第3期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.03.019

接收时间：2025-10-11
首发时间：2026-09-08

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2025-10-11

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.03.019

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT